Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2013-05-07

Clinical Trial Update: HER2 Positive CTC in Advanced Gastric Cancer [NA]

View source ↗

Summary

This clinical trial update concerns HER2-positive advanced gastric cancer. The study status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Peking University | Conditions: HER2 Positive Advanced Gastric Cancer | NA | Status: UNKNOWN